Mol. Cells 2012; 34(1): 15-23
Published online June 25, 2012
https://doi.org/10.1007/s10059-012-0001-x
© The Korean Society for Molecular and Cellular Biology
Correspondence to : *Correspondence: hjchae@chonbuk.ac.kr (HJC); hrkimdp@wonkwang.ac.kr (HRK)
Bax inhibitor-1 (BI-1) is an anti-apoptotic protein located in the endoplasmic reticulum (ER). The role of BI-1 has been studied in different physiopathological models including ischemia, diabetes, liver regeneration and cancer. However, fundamental knowledge about the effects of BI-1 deletion on the proteome is lacking. To further explore this protein, we compared the levels of different proteins in bi-1-/- and bi-1+/+ mouse tissues by two-dimensional electrophoresis (2-DE) and mass spectrometry (MS). In several bi-1-/- mice, glucose-regulated protein 75 (GRP75/mortalin/ PBP74/mthsp70), peroxiredoxin6 (Prx6) and fumarylacetoacetate hydrolase (FAH) showed a pI shift that could be attributed to post-translational modifications. Selenium-binding protein 2 (SBP2) and ferritin light chain 1 levels were significantly increased. Phosphatidylethanolamine-binding protein-1 (PEBP-1) was dramatically decreased in bi-1-/- mice, which was confirmed by Western blotting. The phosphorylation of GRP75, Prx6 and FAH were compared between bi-1+/+ and bi-1-/- mice using liver tissue lysates. Of these three proteins, only one exhibited modified phosphorylation; Tyr phosphorylation of Prx6 was increased in bi-1-/- mice. Our protein profiling results provide fundamental knowledge about the physiopathological function of BI-1.
Keywords 2-DE, Bax inhibitor-1, ER stress, MS, proteomics
Mol. Cells 2012; 34(1): 15-23
Published online July 31, 2012 https://doi.org/10.1007/s10059-012-0001-x
Copyright © The Korean Society for Molecular and Cellular Biology.
Bo Li1, John C. Reed 2, Hyung-Ryong Kim3,*, and Han-Jung Chae1,4,*
1Department of Pharmacology and Cardiovascular Research Center, Chonbuk National University, Jeonju 561-182, Korea, 2Burnham Institute for Medical Research, California 92037, USA, 3Department of Dental Pharmacology, School of Dentistry, Wonkwang University, Iksan 570-749, Korea, 4Research Center for Pulmonary Disorders, Chonbuk National University Hospital, Jeonju 561-182, Korea
Correspondence to:*Correspondence: hjchae@chonbuk.ac.kr (HJC); hrkimdp@wonkwang.ac.kr (HRK)
Bax inhibitor-1 (BI-1) is an anti-apoptotic protein located in the endoplasmic reticulum (ER). The role of BI-1 has been studied in different physiopathological models including ischemia, diabetes, liver regeneration and cancer. However, fundamental knowledge about the effects of BI-1 deletion on the proteome is lacking. To further explore this protein, we compared the levels of different proteins in bi-1-/- and bi-1+/+ mouse tissues by two-dimensional electrophoresis (2-DE) and mass spectrometry (MS). In several bi-1-/- mice, glucose-regulated protein 75 (GRP75/mortalin/ PBP74/mthsp70), peroxiredoxin6 (Prx6) and fumarylacetoacetate hydrolase (FAH) showed a pI shift that could be attributed to post-translational modifications. Selenium-binding protein 2 (SBP2) and ferritin light chain 1 levels were significantly increased. Phosphatidylethanolamine-binding protein-1 (PEBP-1) was dramatically decreased in bi-1-/- mice, which was confirmed by Western blotting. The phosphorylation of GRP75, Prx6 and FAH were compared between bi-1+/+ and bi-1-/- mice using liver tissue lysates. Of these three proteins, only one exhibited modified phosphorylation; Tyr phosphorylation of Prx6 was increased in bi-1-/- mice. Our protein profiling results provide fundamental knowledge about the physiopathological function of BI-1.
Keywords: 2-DE, Bax inhibitor-1, ER stress, MS, proteomics
Yong Jin Heo, Chanwoong Hwa, Gang-Hee Lee, Jae-Min Park, and Joon-Yong An
Mol. Cells 2021; 44(7): 433-443 https://doi.org/10.14348/molcells.2021.0042Jin-Ik Kim, Randal J. Kaufman, Sung Hoon Back, and Ja-Young Moon
Mol. Cells 2019; 42(11): 783-793 https://doi.org/10.14348/molcells.2019.0104Jong-Il Shin, Yong-Joon Jeon, Sol Lee, Yoon Gyeong Lee, Ji Beom Kim, and Kyungho Lee
Mol. Cells 2019; 42(3): 252-261 https://doi.org/10.14348/molcells.2019.2440